Dr Andrew Coleman
Clinical (Lecturer)
The Sir Peter MacCallum Department of Oncology
28 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Prospective Evaluation of Patient Priorities in Human Papillomavirus-Driven Oropharyngeal Cancer Using the Chicago Priorities Scale: Considerations for Future Clinical Trial Design
DOI: 10.1016/j.ijrobp.2025.08.0532025
Journal article
Anxiety, Depression and Fear of Cancer Recurrence (FCR) in HPV-Associated Oropharyngeal Cancer (HPVOPC) Survivors Treated with Chemoradiation (CRT): Implications for Contemporary Clinical Care
DOI: 10.1016/j.ijrobp.2025.06.23312025
Journal article
Final Results From a Longitudinal Observation Study Evaluating Sexual Health and Facial Appearance and Distress in Human Papillomavirus-Associated Oropharyngeal Cancer Survivors Treated With Chemoradiotherapy
DOI: 10.1016/j.ijrobp.2025.02.0042024
Journal article
Treatment Outcome Priorities for Patients with Human Papillomavirus-Associated Oropharyngeal Cancer (HPVOPC) before and 12 Months after Primary (Chemo) Radiation (CRT/RT): Results from a Prospective Longitudinal Observational Study
DOI: 10.1016/j.ijrobp.2024.07.16962024
Journal article
Sexual Health, Facial Appearance and Appearance Distress in Patients with Human Papillomavirus-Associated Oropharyngeal Cancer (HPVOPC) Patients Undergoing (Chemo)Radiation (CRT/RT): Final Results from a Prospective Longitudinal Observational Study
DOI: 10.1016/j.ijrobp.2024.07.16972024
Journal article
A Longitudinal Study Evaluating Sexual Health Outcomes and Prioritization in Patients Undergoing Chemoradiation for Human Papillomavirus-Associated Oropharyngeal Cancer
DOI: 10.1016/j.ijrobp.2023.10.0062023
Conference Proceedings
Fear of Cancer Recurrence (FCR) in Human PapillomavirusAssociated Oropharyngeal Cancer (HPVOPC) Patients 12 months (12m) after (Chemo)Radiation (RT/CRT)
DOI: 10.1016/j.ijrobp.2023.06.1192
RECENT SCHOLARLY WORKS
2023
Conference Proceedings
A Prospective Study Evaluating Sexual Health Outcomes in Patients Undergoing (Chemo)Radiation (CRT/RT) for Human Papillomavirus-Associated Oropharyngeal Cancer (HPVOPC)
DOI: 10.1016/j.ijrobp.2023.06.4602023
Journal article
Treatment outcomes of standard (high dose) cisplatin and non-standard chemotherapy for locally advanced head and neck cancer
DOI: 10.1002/cnr2.16742022
Journal article
Ga-68-prostate-specific membrane antigen (PSMA) PET/CT as a clinical decision-making tool in biochemically recurrent prostate cancer
DOI: 10.1111/ajco.13595